The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis

It is widely accepted that senescent cells accumulate with aging. They are characterized by replicative arrest and the release of a myriad of factors commonly called the senescence-associated secretory phenotype. Despite the replicative cell cycle arrest, these cells are metabolically active and fun...

Full description

Bibliographic Details
Main Authors: Kay-Dietrich Wagner, Nicole Wagner
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/12/1966
_version_ 1797488933911658496
author Kay-Dietrich Wagner
Nicole Wagner
author_facet Kay-Dietrich Wagner
Nicole Wagner
author_sort Kay-Dietrich Wagner
collection DOAJ
description It is widely accepted that senescent cells accumulate with aging. They are characterized by replicative arrest and the release of a myriad of factors commonly called the senescence-associated secretory phenotype. Despite the replicative cell cycle arrest, these cells are metabolically active and functional. The release of SASP factors is mostly thought to cause tissue dysfunction and to induce senescence in surrounding cells. As major markers for aging and senescence, p16INK4, p14ARF/p19ARF, and p21 are established. Importantly, senescence is also implicated in development, cancer, and tissue homeostasis. While many markers of senescence have been identified, none are able to unambiguously identify all senescent cells. However, increased levels of the cyclin-dependent kinase inhibitors p16INK4A and p21 are often used to identify cells with senescence-associated phenotypes. We review here the knowledge of senescence, p16INK4A, p14ARF/p19ARF, and p21 in embryonic and postnatal development and potential functions in pathophysiology and homeostasis. The establishment of senolytic therapies with the ultimate goal to improve healthy aging requires care and detailed knowledge about the involvement of senescence and senescence-associated proteins in developmental processes and homeostatic mechanism. The review contributes to these topics, summarizes open questions, and provides some directions for future research.
first_indexed 2024-03-10T00:09:22Z
format Article
id doaj.art-a32db0a28fab4333b2df33b14a5c0b38
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T00:09:22Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-a32db0a28fab4333b2df33b14a5c0b382023-11-23T16:02:19ZengMDPI AGCells2073-44092022-06-011112196610.3390/cells11121966The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and HomeostasisKay-Dietrich Wagner0Nicole Wagner1CNRS, INSERM, iBV, Université Côte d’Azur, 06107 Nice, FranceCNRS, INSERM, iBV, Université Côte d’Azur, 06107 Nice, FranceIt is widely accepted that senescent cells accumulate with aging. They are characterized by replicative arrest and the release of a myriad of factors commonly called the senescence-associated secretory phenotype. Despite the replicative cell cycle arrest, these cells are metabolically active and functional. The release of SASP factors is mostly thought to cause tissue dysfunction and to induce senescence in surrounding cells. As major markers for aging and senescence, p16INK4, p14ARF/p19ARF, and p21 are established. Importantly, senescence is also implicated in development, cancer, and tissue homeostasis. While many markers of senescence have been identified, none are able to unambiguously identify all senescent cells. However, increased levels of the cyclin-dependent kinase inhibitors p16INK4A and p21 are often used to identify cells with senescence-associated phenotypes. We review here the knowledge of senescence, p16INK4A, p14ARF/p19ARF, and p21 in embryonic and postnatal development and potential functions in pathophysiology and homeostasis. The establishment of senolytic therapies with the ultimate goal to improve healthy aging requires care and detailed knowledge about the involvement of senescence and senescence-associated proteins in developmental processes and homeostatic mechanism. The review contributes to these topics, summarizes open questions, and provides some directions for future research.https://www.mdpi.com/2073-4409/11/12/1966developmentagingendothelial cellssenescenceSASPmetabolic function
spellingShingle Kay-Dietrich Wagner
Nicole Wagner
The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
Cells
development
aging
endothelial cells
senescence
SASP
metabolic function
title The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
title_full The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
title_fullStr The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
title_full_unstemmed The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
title_short The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
title_sort senescence markers p16ink4a p14arf p19arf and p21 in organ development and homeostasis
topic development
aging
endothelial cells
senescence
SASP
metabolic function
url https://www.mdpi.com/2073-4409/11/12/1966
work_keys_str_mv AT kaydietrichwagner thesenescencemarkersp16ink4ap14arfp19arfandp21inorgandevelopmentandhomeostasis
AT nicolewagner thesenescencemarkersp16ink4ap14arfp19arfandp21inorgandevelopmentandhomeostasis
AT kaydietrichwagner senescencemarkersp16ink4ap14arfp19arfandp21inorgandevelopmentandhomeostasis
AT nicolewagner senescencemarkersp16ink4ap14arfp19arfandp21inorgandevelopmentandhomeostasis